Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year.
EnBio Holdings's 10-Year ROIIC % for the quarter that ended in Mar. 2026 was 2.21%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for EnBio Holdings's 10-Year ROIIC % or its related term are showing as below:
TSE:6092's 10-Year ROIIC % is ranked worse than 57.55% of 834
companies
in the Business Services industry
Industry Median: 4.8
vs TSE:6092: 2.21
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
EnBio Holdings 10-Year ROIIC % Related Terms
EnBio Holdings 10-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for EnBio Holdings's 10-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6092 vs CTAS, CPRT, GPN: 10-Year ROIIC % Comparison
For the Specialty Business Services subindustry, EnBio Holdings's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EnBio Holdings 10-Year ROIIC % vs Business Services Industry
For the Business Services industry and Industrials sector, EnBio Holdings's 10-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where EnBio Holdings's 10-Year ROIIC % falls into.
EnBio Holdings's 10-Year ROIIC % for the quarter that ended in Mar. 2026 is calculated as:
10-Year ROIIC %
=
10-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
10-Year Incremental Invested Capital**
=
( 445.8726 (Mar. 2026) - 171.715388 (Mar. 2016) )
/
( 17098 (Mar. 2026) - 4705.789 (Mar. 2016) )
=
274.157212
/
12392.211
=
2.21%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
EnBio Holdings (TSE:6092) has a 10-Year ROIIC % of 2.21 as of Mar. 2026. 10-Year ROIIC % measures the change in earnings as a percentage of change in investment over 10-year. View historical data on EnBio Holdings and its competitors. According to the industry distribution chart, EnBio Holdings ranks #480 out of 834 companies in the Business Services industry, placing it in the top 57.6%.
Is EnBio Holdings' 10-Year ROIIC % too high?
EnBio Holdings' current 10-Year ROIIC % is 2.21. The Business Services industry median 10-Year ROIIC % is 4.80. EnBio Holdings' value of 2.21 is 54% below this industry median. Based on the distribution chart, EnBio Holdings ranks #480 out of 834 companies in the Business Services industry, which is below the industry midpoint. Overall, EnBio Holdings has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EnBio Holdings' 10-Year ROIIC % compare to CTAS and CPRT?
According to the Business Services industry distribution chart, EnBio Holdings ranks #480 out of 834 companies for 10-Year ROIIC %. This places EnBio Holdings in the lower half of its industry. The industry median 10-Year ROIIC % is 4.80. EnBio Holdings' value of 2.21 is 54% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year ROIIC % for a Business Services company?
The median 10-Year ROIIC % among Business Services companies is 4.80, based on 834 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EnBio Holdings's current 10-Year ROIIC % of 2.21 is 54% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year ROIIC % mean?
A high 10-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 10-Year ROIIC % measures the change in earnings as a percentage of change in investment over 10-year. View historical data on EnBio Holdings and its competitors. For the Business Services industry, the median 10-Year ROIIC % is 4.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EnBio Holdings's current 10-Year ROIIC % is 2.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EnBio Holdings stock overvalued right now?
Based on GuruFocus' analysis, EnBio Holdings (TSE:6092) is currently considered Fairly Valued. The stock's GF Value™ is 円805.37, compared to a current price of 円884.00 — trading 9.8% above its estimated fair value. The current 10-Year ROIIC % is 2.21 and 54% below the Business Services industry median of 4.80. EnBio Holdings' overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year ROIIC % calculated?
10-Year ROIIC % is calculated from a company's financial statements. For EnBio Holdings (TSE:6092), the current 10-Year ROIIC % is 2.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EnBio Holdings (TSE:6092) Overvalued in 2026?
Based on GuruFocus' analysis, EnBio Holdings stock appears to be overvalued.
The current stock price of 円884.00 is trading 9.8% above its estimated GF Value™ of 円805.37.
GuruFocus considers EnBio Holdings to be Fairly Valued.
Key valuation signals for TSE:6092:
10-Year ROIIC %: 2.21
GF Value™: 円805.37 vs. price of 円884.00 (9.8% above fair value)
Industry Position: 54% below the Business Services median (#480 of 834)
No single metric tells the full story. See the TSE:6092 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EnBio Holdings Inc is a Japanese company engaged in environmental solution business, tools and chemicals business, and brownfield revitalization business. The environmental business involves investigation, remediation and risk management consulting of contaminated soil and groundwater; Tools and chemicals business involves sales of chemicals used for environmental work such as site investigation and remediation; and brownfield revitalization business which involves purchasing and regeneration of brownfields. The objective of the company is solving soil and groundwater contamination issues.
58GF Score
Get the complete analysis for TSE:6092
10-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6092 has been successfully added to your 
